United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | |
| Cash Flows From Operating Activities | |
| Net Income | -33,507 |
| Depreciation Amortization | -1,251 |
| Accounts receivable | -80 |
| Accounts payable and accrued liabilities | 222 |
| Other Working Capital | 2,055 |
| Other Operating Activity | 8,867 |
| Operating Cash Flow | $-23,693 |
| Cash Flows From Investing Activities | |
| Change In Deposits | -21,761 |
| PPE Investments | -1,992 |
| Net Acquisitions | -313 |
| Investing Cash Flow | $-24,066 |
| Cash Flows From Financing Activities | |
| Debt Issued | 1,798 |
| Debt Repayment | -13 |
| Common Stock Issued | 58,377 |
| Other Financing Activity | -902 |
| Financing Cash Flow | $59,260 |
| Beginning Cash Position | 6,779 |
| End Cash Position | 18,280 |
| Net Cash Flow | $11,501 |
| Free Cash Flow | |
| Operating Cash Flow | -23,693 |
| Capital Expenditure | -1,995 |
| Free Cash Flow | -25,688 |